المؤلفون: Kelly, Richard J., Holt, Matthew, Vidler, Jennifer, Arnold, Louise M., Large, Joanna, Forrest, Briony, Barnfield, Catherine, Pike, Alexandra, Griffin, Morag, Munir, Talha, Muus, Petra, Nagumantry, Sateesh K., Varghese, Abraham, Davies, John R., Trikha, Roochi, Kulasekararaj, Austin G., Mitchell, Lindsay, Gandhi, Shreyans

المصدر: In Blood 21 March 2024 143(12):1157-1166

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Fattizzo, Bruno^{Aff1, Aff2, Aff3}, Ireland, Robin, Dunlop, Alan, Yallop, Deborah, Kassam, Shireen, Large, Joanna, Gandhi, Shreyans, Muus, Petra, Manogaran, Charles, Sanchez, Katy, Consonni, Dario, Barcellini, Wilma, Mufti, Ghulam J.^{Aff1, Aff4}, Marsh, Judith C. W.^{Aff1, Aff4}, Kulasekararaj, Austin G.^{Aff1, Aff4}

المصدر: Leukemia. 35(11):3223-3231

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Muus, Petra ^*, Langemeijer, Saskia, van Bijnen, Sandra, Blijlevens, Nicole, de Witte, Theo

المصدر: In Leukemia Research June 2021 105

المؤلفون: AMADORI, Sergio, SUCIU, Stefan, SELLESLAG, Dominik, ROSSETTI, Elena, GAIDANO, Gianluca, MUSSO, Maurizio, ANNINO, Luciana, VENDITTI, Adriano, MAGRO, Domenico, DE FABRITIIS, Paolo, MUUS, Petra, ALIMENA, Giuliana, MANCINI, Marco, HAGEMEIJER, Anne, COTUGNO, Francesca, VIGNETTI, Marco, FAZI, Paola, MEERT, Liv, RAMADAN, Safaa M., WILLEMZE, Roelof, DE WITTE, Theo, BARON, Frédéric

المصدر: Improved overall survival with Gemtuzumab Ozogamicin (GO) compared with best supportive care (BSC) in elderly patients with untreated acute myeloid leukemia (AML) not considered fit for intensive chemotherapy: final results from the randomized phase III study (AML-19) of the EORTC and gimema leukemia groups. Blood, 124(21), 619.Washington, DCAmerican Society of Hematology. (2014).

مصطلحات موضوعية: Human health sciences :: Hematology, Sciences de la santé humaine :: Hématologie

Relation: 56th ASH Annual Meeting and Exposition, San Francisco, USA (du 6 décembre 2014 au 9 décembre 2014)

URL الوصول: https://orbi.uliege.be/handle/2268/188179

المؤلفون: SELLESLAG, Dominik L.D., SUCIU, Stefan, MELONI, Giovanna, MUUS, Petra, HALKES, Constantijn J.M., VENDITTI, Adriano, RAMADAN, Safaa M., PRUIJT, Hans, MEERT, Liv, VIGNETTI, Marco, MARIE, Jean-Pierre, BRON, Dominique, DE WITTE, Theo, AMADORI, Sergio, WILLEMZE, Roelof, BARON, Frédéric

المصدر: Clofarabine in combination with a standard remission induction regimen in patients 18-60 years old previously untreated intermediate an bad risk actue myelogenous leukemia (AML) or high risk myelodysplasia (MDS): combined phase I/II results of the EORTC/Gimema AML-14A trial. Blood, 124(21), 3675.Washington, DCAmerican Society of Hematology. (2014).

مصطلحات موضوعية: Human health sciences :: Hematology, Sciences de la santé humaine :: Hématologie

Relation: 56th ASH Annual Meeting and Exposition, San Francisco, USA (du 6 décembre 2014 au 9 décembre 2014)

URL الوصول: https://orbi.uliege.be/handle/2268/188181

المؤلفون: Langemeijer, Saskia, Schaap, Charlotte, Preijers, Frank, Jansen, Joop H., Blijlevens, Nicole, Inoue, Norimitsu, Muus, Petra, Kinoshita, Taroh, Murakami, Yoshiko

المصدر: In Blood Advances 24 November 2020 4(22):5755-5761

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.